It included detailed claims about the product, which it said was perfect for people with big appetites or anyone whos tried GLP-1 drops or injections without much result
It is administered as a once-weekly subcutaneous injection, typically in the abdomen, thigh, or upper arm, with doses gradually increased over time to minimize gastrointestinal side effects
The search included terms such as small molecule GLP-1 receptor agonists, oral GLP-1 receptor agonists, Danuglipron, Orforglipron, and Aleniglipron. Additionally, information on ongoing clinical trials involving small molecule GLP-1 receptor agonists was retrieved from the ClinicalTrials.gov database using the same keywords
If you take other diabetes medications, particularly insulin or sulfonylureas, your provider will need to adjust those medications when restarting semaglutide to avoid hypoglycemia
If side effects become problematic, your healthcare provider can extend the time at your current dose, pause advancement temporarily, or recommend staying at a lower therapeutic level